Associations of Serum Trimethylamine N-oxide, Choline, Carnitine, and Betaine with Colorectal Cancer Risk |
Doratha Byrd |
Moffitt Cancer Center |
PLCO |
Dec 27, 2019 |
2019-1004 |
Instrumental variable methods in survival outcome |
Youjin Lee |
University of Pennsylvania |
PLCO |
Dec 16, 2019 |
PLCO-561 |
Blood metabolomics, smoking and lung cancer risk |
Wei Jie Seow |
National University of Singapore |
PLCO |
Dec 16, 2019 |
PLCO-558 |
Analyses using GWAS data from PLCO to evaluate genetic impact on colorectal screening and outcomes |
Wen-Yi Huang |
National Cancer Institute |
PLCO |
Dec 11, 2019 |
PLCO-560 |
Magnesium intake and primary liver cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Guo-Chao Zhong |
The Second Affiliated Hospital of Chongqing Medical University |
PLCO |
Dec 11, 2019 |
PLCO-559 |
Integrating Genomics and Metabolomics to Develop Predictive Models of Prostate Cancer in Multiethnic Men |
Burcu Darst |
University of Southern California |
PLCO |
Nov 26, 2019 |
PLCO-555 |
Associations of Dietary Inflammatory and Insulinemic Potential with Risk of Cancer Development |
Fred Tabung |
The Ohio State University College of Medicine |
PLCO |
Nov 25, 2019 |
PLCO-553 |
Association of endogenous estrogens, estrogen metabolites, androgens and androgen metabolites with Ovarian Cancer |
Britton Trabert |
NIH |
PLCO |
Nov 21, 2019 |
2016-0047 |
Drinking and pre-diagnosed BMI trajectories and their impact on the mortality of upper-gastrointestinal cancers in the PLCO population. |
Jianjun Li |
Sun Yat-Sen University Caner Center |
PLCO |
Nov 13, 2019 |
PLCO-546 |
Machine Learning Application of Cancer Data Analysis |
Mochen Li |
Purdue University |
PLCO |
Nov 13, 2019 |
PLCO-552 |
Incorporating Biomarkers to Improve Lung Cancer Risk Prediction |
Samir Hanash |
University of Texas at MD Anderson |
PLCO |
Nov 4, 2019 |
PLCO-549 |
Dietary Inflammatory Index and risk of differentiated thyroid cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial |
Li Chen |
Department of the Endocrine and Breast Surgery, The First Affiliated hospital of Chongqing Medical university |
PLCO |
Oct 24, 2019 |
PLCO-543 |
Machine Learning to select patients benefiting from prostate cancer screening |
Jean-Emmanuel Bibault |
Laboratory of Artificial Intelligence in Medicine and Biomedical Physics, Stanford University |
PLCO |
Oct 24, 2019 |
PLCO-541 |
Predicting Cancer diagnosis based on preliminary screenings |
Jonathan Mendoza |
Independent |
PLCO |
Oct 24, 2019 |
PLCO-532 |
Evaluation of Patients Data using AI techniques and It's Application in Pancreatic Cancer Differential Diagnosis |
Wanessa Sena |
Federal Institute of Pernambuco |
PLCO |
Oct 10, 2019 |
PLCO-539 |
Link-based survival additive models with mixed types of censoring. |
Giampiero Marra |
University College London |
PLCO |
Oct 8, 2019 |
PLCO-538 |
Inflammatory potential of diet and risk of ovarian cancer by menopausal status in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial |
Zhuyue Li |
West China Hospital |
PLCO |
Oct 8, 2019 |
PLCO-536 |
“Development of a probabilistic network for clinical pathways based on patient cohort characteristics, outcome-indicators and clinical workflow analysis to create artificial patients with prostatic adenocarcinoma” |
Andrea Riedel |
Institute for general practitioners |
PLCO |
Oct 8, 2019 |
PLCO-535 |
Tobacco smoking is associated with increased tumor grade and stage and grade along with the mucinous carcinoma histopathologic type. |
Rodger Rothenberger |
University of Cincinnati |
PLCO |
Oct 3, 2019 |
PLCO-534 |
A Comparison Between Multi Classification Algorithms on PLCO Colorectal Cancer Dataset |
Bawer Berwary |
Van Yuzuncu Yil University |
PLCO |
Oct 3, 2019 |
PLCO-533 |